Compare GENC & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GENC | APYX |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | 318 | 205 |
| Industry | Construction/Ag Equipment/Trucks | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 169.6M |
| IPO Year | 1995 | 1995 |
| Metric | GENC | APYX |
|---|---|---|
| Price | $14.54 | $3.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $17.60 | $6.50 |
| AVG Volume (30 Days) | 15.5K | ★ 221.1K |
| Earning Date | 02-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.08 | ★ 19.40 |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $48,943,000.00 | N/A |
| Revenue This Year | N/A | $11.93 |
| Revenue Next Year | $25.51 | $11.01 |
| P/E Ratio | $62.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.22 | $1.36 |
| 52 Week High | $17.40 | $4.50 |
| Indicator | GENC | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 46.15 | 53.69 |
| Support Level | $13.82 | $3.82 |
| Resistance Level | $14.59 | $4.28 |
| Average True Range (ATR) | 0.52 | 0.38 |
| MACD | -0.04 | 0.08 |
| Stochastic Oscillator | 23.49 | 68.79 |
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.